After PSM, 81,152 participants remained in the SGLT2i group, and 20,288 participants remained in the GLP1RA group (Fig
Peptide therapy is generally considered safe , but potential side effects may include irritation at the injection site, allergic reactions, or changes in mood
Semaglutide is more effective than liraglutide, and tirzepatide appears more effective than semaglutide
For maximum benefit, it is recommended to have one injection per week for 4 weeks, then maintain with one injection every 3 months
Phase 2 Human Trials: Modest but Real Fat Loss Metabolic Pharmaceuticals conducted a Phase 2b randomized, double-blind, placebo-controlled trial in approximately 300 obese adults
It's simpler and safer for the molecule